🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the side effects and best dose of ruxolit...
Status
Completed
Location
City of Hope Medical Center
Start Date
2016-11-13
Trial ID
NCT02917096
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Status
Terminated
Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Start Date
2003-11
Trial ID
NCT00670410
Treatments Being Tested
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
This is a prospective, open-label, nonrandomized, prospective clinical tria...
Status
Completed
Location
Children's Hospital of Alabama/UAB
Start Date
2013-09
Trial ID
NCT01772953
Treatments Being Tested
RATIONALE: Photopheresis treats the patient's blood with drugs and ultravio...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-10-24
Trial ID
NCT00045305
RATIONALE: Giving chemotherapy and total body irradiation before a donor bo...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-08
Trial ID
NCT00028730
RATIONALE: Giving chemotherapy drugs, such as busulfan and etoposide, and i...
Status
Terminated
Location
City of Hope
Start Date
2007-06-11
Trial ID
NCT00540995
Patients in need of an allogeneic hematopoietic cell transplant (HCT) are a...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2019-12-19
Trial ID
NCT04337515
Treatments Being Tested
This phase II trial studies how well cyclophosphamide works in preventing c...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2011-09
Trial ID
NCT01427881